INDUSTRY COLLABORATION & PARTNERS

The CoE engages in interactions with industry collaborators across numerous life sciences areas - biotechnology, biomedical informatics, diagnostics, medical devices, pharmaceuticals, research and development - that relate to the translational research capabilities of the CoE. By combining its resources with those of industry collaborators, the CoE furthers the goal of creating new life sciences technologies that improve the health and well-being of the population.

The CoE is already working with numerous industry organizations in synergistic relationships, including Cognigen Corporation, Dell, General Electric Global Research, Hewlett-Packard, Invitrogen Corporation, Oracle Corporation, Pfizer Inc, Silicon Graphics Inc, SofTrek/Appitat, Stryker Corp, Sun and Tata Consultancy Services. At the same time, the CoE is launching a new Corporate Partner & Sponsors Program to expand its industry relationships.

To receive periodic corporate and community event updates from the CoE, please join our mailing list.


New York State Center of Excellence
in Bioinformatics & Life Sciences
invites you to join our

Partner Program

If you are from a life sciences or related organization, you are ideal for the Corporate Partner Program.


If you are not from a life sciences organization, but want to support the growth of life sciences, you are ideal for the Community Partner Program.


Click on the Programs above for more details on these opportunities or to request more information, click here.

 

Thank you to the Members of the Center of Excellence Corporate & Community Partner Program!

National Grid

Buffalo Niagara Enterprise

Applied Sciences Group                                                     Buffalo BioSciences

ComDoc                                                                                      CTG

Oracle                                                                  SofTrek


News

Study Describes Mechanism Linking Alcohol with Risk of Breast Cancer
04/30/2008 - BUFFALO, N.Y. -- The known association of alcohol consumption with an increased risk of breast cancer has been linked by researchers at the University at Buffalo to a process that causes genes that promote normal cell growth to produce proteins that precipitate unregulated cell growth, an action known as hypermethylation...[Read On...]

Common Plant Component Shows Potential as MS Treatment
04/17/2008 - BUFFALO, N.Y. -- Plant sterols, known to help reduce high cholesterol, also may be effective in treating the effects of multiple sclerosis (MS), novel research by University at Buffalo investigators has shown.  The study, lead by Forum M. Desai, a student in the UB Department of Exercise and Nutrition Sciences, has shown that Beta-sitosterol, a compound found in most vegetables and fruits, can reduce secretion of several proinflammatory factors known to be involved in damage to the brain's myelin...[Read On...]

Visit the News Archive

Events

May 6 - Dr. Austin Clean Room Program
Don’t miss the opportunity to hear one of the world’s foremost Cleanroom and Contamination Control Experts.  Dr. Austin has published six textbooks on clean rooms and personally authored each of the clean room standards adopted by ISO.   This program will take place from 2-6pm Roswell Park Cancer Institute, Center for Genetics & Pharmacology, Zebro Room, 701 Ellicott Street, Buffalo, NY.   Register at www.thepartnership.org/events. See flyer for more information. HWI 2007

May 8 HWI Seminar Series
Please join Dr. Michael Rossman from Purdue University for a presentation on “Symmetry and asymmetry in the control of viral assembly, maturation and infection”. Program begins at 2:30pm with a reception to follow. Series is held at the Hauptman-Woodward Institute 700 Ellicott Street, Buffalo, NY 14203. HWI 2007


To view the complete list of events and event details, please visit our Events page

To receive periodic News & Events emails from the COE, please join our mailing list!

701 Ellicott Street ~ Buffalo, New York 14203 ~ 716.881.8900home | privacy policy | contact us